Medical Device News Magazine

Cerner and Xealth Collaboration: Working to Improve the Healthcare Experience and Empower Patients to Be Active Participants in their Treatment and Well-Being

Collaboration will Bring Digital Health Tools to Clinicians and Patients to Improve the Health Care Experience

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

August 6, 2020

Xealth, the leader in enabling digital health at scale, and Cerner Corporation (NASDAQ: CERN), a global health care technology company, are working to improve the health care experience and empower patients to be active participants in their treatment and well-being. As part of this agreement, Cerner and LRVHealth have together invested $6 million in Xealth.

At its core, the relationship between Xealth and Cerner aims to give patients their own digital data so they can be more engaged in their treatment plans. The Xealth platform is designed to help clinicians easily integrate, prescribe and monitor digital health tools for patients from one location in the EHR.

Care teams will be able to order solutions directly from the EHR to manage conditions including chronic diseases, behavioral health, maternity care and surgery preparation. Incorporating Xealth into Cerner’s technology and patient portal will provide easier access to personal health information and give care teams the ability to monitor patient engagement with the tools, as well as analyze the effects of increased engagement on the patient’s health care and recovery.

During the recent surge of COVID-19 across the world, tools that automate patient education, deliver virtual care, support telehealth and offer remote patient monitoring have become even more prominent, creating new methods to inform care decisions and keep care teams and patients connected.

“Today, we have the unique opportunity to improve people’s lives by allowing active participation in their own treatment plans,” said David Bradshaw, Senior Vice President, Consumer and Employer Solutions, Cerner. “Patients want greater access to their health information and are motivated to help care teams find the most appropriate road to recovery. Xealth and Cerner hope to make it easier and more convenient for patients and clinicians to accelerate health care in a more consumer-centric experience.”

The collaboration between Cerner and Xealth will provide care teams and patients convenience and help improve care accessibility. Better communications and engagement between patients and key members of their care team will create an experience that is connected across settings before, during and after a care encounter. Xealth powers more than 30 digital health solutions, connecting patients with educational content, remote patient monitoring, virtual care platforms, e-commerce product recommendations and other services needed to improve health outcomes.

“In order for digital health to have lasting impact, it needs to show value and ease for both the care team and patient,” said Mike McSherry, CEO and Co-Founder of Xealth. “We strongly believe that technology should nurture deeper patient-provider relationships and facilitate information sharing across systems and the care settings. It is exciting to work with Cerner to simplify meaningful digital health for its health partners.”

Cerner and LRVHealth join Xealth investors Atrium Health, Cleveland Clinic, Froedtert and the Medical College of Wisconsin, MemorialCare Innovation Fund, Providence Ventures and UPMC as well as Threshold Ventures, McKesson, Novartis, Philips, and ResMed.

“Combining our expertise in developing interactive digital solutions that improve the patient experience with Cerner’s world-class platforms creates immense opportunity for our clients to better meet the needs of today’s highly connected health care consumer,” concluded McSherry.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”